Prophylactic effect of the anti-inflammatory drug diclofenac in experimental schistosomiasis mansoni

International Journal of Infectious Diseases

Volumn 11, Issue 2, 2007, Pages 161-165

  Nessim, Nevine Guirguis ^a   Mahmoud, Soheir ^a  

^a Giza   (Egypt)

Author keywords

Diclofenac; Experimental schistosomiasis mansoni; Hepatic granuloma measurement; Immature worms; Mature worms and tissue egg load

Indexed keywords

DICLOFENAC POTASSIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; INFECTION PREVENTION; LIVER GRANULOMA; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TUMOR VOLUME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; GRANULOMA; LIVER DISEASES, PARASITIC; MICE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 33847133379     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2006.01.004     Document Type: Article

References (19)

1. Utzinger J., Xiao S., N'Goran E.K., Bergquist R., and Tanner M. The potential of artemether for the control of schistosomiasis. Int J Parasitol 31 (2001) 1549-1562
2. Sangster N.C. Managing parasiticide resistance. Vet Parasitol 98 (2001) 89-109
3. Ojewole J.A., and Adewunmi C.O. Anti-inflammatory and hypoglycaemic effects of Tetrapleura tetraptera (Taub) (Fabacaea) fruit aqueous extracts in rats. J Ethnopharmacol 2-3 (2004) 177-182
4. Farag M.M., Salama M.A., and Abou-Basha L. Experimental murine schistosomiasis reduced hepatic morbidity after pre and post-infection treatment with ibuprofen or diclofenac sodium. Ann Trop Med Parasitol (1995) 497-504
5. Nessim N.G., Hassan S.I., William S., and El Baz H. Effect of the broad spectrum anthelmintic drug flubendazole upon Schistosoma mansoni experimentally infected mice. Arzneimittelforschung/Drug Research 50 (2000) 1129-1133
6. Duvall R.H., and De Witt W.B. An important perfusion technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg 16 (1967) 483-486
7. Harris H.F. On the rapid conversion of haematoxylin into haematin staining reactions. J App Mic Lab Methods 3 (1900) 777. Quoted from: Arzneim Forsch/Drug Res 2003;53:440-4 Treatment of acute schistosomiasis mansoni with praziquantel and an antifibrotic agent in mice.
8. Giboda M., Jacobs P., Smith J.M., and Miller S.C. Immune response of mice infected with Schistosoma mansoni is modulated by antifibrotic treatment. Ann Trop Med Parasitol 89 (1995) 415-429
9. Hassan S.I., Aly I., Guirguis N., and Amer M. Resistance to challenge in mice with chronic Schistosoma mansoni treated with praziquantel and an antifibrotic agent. Kasr El Eini Medical Journal 10 (2004) 213-219. Quoted from: Arzneim Forsch/Drug Res 2003;53:440-444. Treatment of acute schistosomiasis mansoni with praziquantel and an antifibrotic agent in mice.
10. Mansy S.S., Yehia H.A., Hassan M.M., Hassan E.A., Youssef M.M., Abdel Hadi A.A., et al. Octreotide decreases connective tissue formation and improves vascular changes associated with hepatic schistosomiasis. J Egypt Soc Parasitol 28 (1998) 23-44
11. Badawy A.A., El-Badrawy N.M., Hassan M.M., and Ebeid F.A. Colchicine therapy for hepatic murine schistosomal fibrosis: image analysis and serological study. Int J Exp Path 80 (1999) 25-34
12. Hesse M., Cheever A.W., Jankovic D., and Wynn T.A. NOS-2 mediates the protective anti-inflammatory and antifibrotic effect of the Th-1 inducing adjuvant, IL-2, in a Th2 model of granulomatous disease. Am J Pathol 157 (2000) 945-995
13. Gross T.J., and Hunninghake G.W. Idiopathic pulmonary fibrosis. N Engl J Med 345 (2001) 517-525
14. Botros S.S., El Badrawy N., Metwally A.A., and Khayyal M.T. Study of some immunopharmacological properties of praziquantel in experimental schistosomiasis mansoni. Ann Trop Med Parasitol 80 (1986) 189-196
15. Hassan S.I., Botros S.S., El Nahhal H.M., Azab M.E., Shaker Z.A., and El-Garem A.A. Effect of specific chemotherapy on the immune response and resistance to reinfection in experimental Schistosoma mansoni. Int J Immunopharmacol 12 (1990) 207-215
16. Pancera C.F., Alves A.L., Paschoalotti M.A., and Chieffi P.P. Effect of wide spectrum drugs upon Schistosoma mansoni infected mice. Rev Inst Med Trop S Paulo 39 (1979) 159-163
17. Chatterjee S., and Van Marck E. The role of somatostatin in schistosomiasis: a basis for immunomodulation in host-parasite interactions. Trop Med Int Health 6 (2001) 578-581
18. Doenhoff M.J., Stanley R.G., Pryce D., Curtis R.C., Parry H., Griffiths K., et al. Identification of a fibrinolytic enzyme in Schistosoma mansoni eggs and modulated blood fibrinogen metabolism in S. mansoni-infected mice. Parasitology 126 (2003) 231-234
19. Pyrrho A.S., Lenzi H.L., Ramos J.A., Moura-Neto R., Cachem F.C., Santos da Silva C., et al. Dexamethasone treatment improves morphological and hematological parameters in chronic experimental schistosomiasis. Parasitol Res 92 (2004) 478-483